Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01565681 · ClinicalTrials.gov registry record · Phase 1
Study of ASKP1240 After a Single Intravenous Dose at Escalating Dose Levels in Healthy Subjects
A Phase 1 study, sponsored by Astellas Pharma Global Development.
- Completed
- Registry status
- Phase 1
- Development phase
- 109
- Enrollment target
NCT01565681: Completed Phase 1 study, sponsored by Astellas Pharma Global Development.
NCT01565681 is a Phase 1 study that has completed, run by Astellas Pharma Global Development. The registered enrollment target is 109 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (82% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01565681, a Phase 1 study, has completed, sponsored by Astellas Pharma Global Development.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 109 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the safety, tolerability, pharmacodynamics and pharmacokinetics of ASKP1240 after a single intravenous dose at escalating dose levels in healthy subjects.
Primary Outcome
binding of ASKP1240-biotin to B cells
Interventions
- DRUG Placebo
- DRUG ASP1240
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 109 participants |
| Start Date | 2009-01 |
| Est. Completion | 2009-12 |
| Phase | Phase 1 |
What the finished NCT01565681 record still lists
NCT01565681 is an interventional study that assigns participants to a tested intervention. The registered 109 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (82% higher).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01565681 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01565681 about?
NCT01565681 is a clinical study titled "Study of ASKP1240 After a Single Intravenous Dose at Escalating Dose Levels in Healthy Subjects". The objective of this study is to evaluate the safety, tolerability, pharmacodynamics and pharmacokinetics of ASKP1240 after a single intravenous dose at escalating dose levels in healthy subjects.
What is the current status of trial NCT01565681?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 109 participants. The study started on 2009-01. Estimated completion is 2009-12.
What interventions are being tested in trial NCT01565681?
The interventions under investigation include: Placebo (DRUG), ASP1240 (DRUG).
Who is sponsoring clinical trial NCT01565681?
This trial is sponsored by Astellas Pharma Global Development, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01565681's enrollment target sits among peer trials
109 522nd of 2000 higher than 1,478 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02421380 · 109 participants · NA
Characterization of Hyperpolarized Pyruvate MRI Reproducibility
- NCT04526600 · 109 participants · NA
Fidgeting and Attentional and Emotional Regulation in ADHD
- NCT04835584 · 109 participants · Phase 1
KRT-232 and TKI Study in Chronic Myeloid Leukemia
- NCT06626516 · 109 participants · Phase 1
Tebentafusp-tebn With LDT in Metastatic UM
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia